Biochemical and Biophysical Research Communications 1992-06-15

bFGF enhances the development of the collateral circulation after acute arterial occlusion.

J O Chleboun, R N Martins, C A Mitchell, T V Chirila

Index: Biochem. Biophys. Res. Commun. 185(2) , 510-6, (1992)

Full Text: HTML

Abstract

An adequate collateral circulation is crucial to tissue survival subsequent to proximal major arterial occlusion. The precise mechanism of collateral blood vessel development and the biochemical mediators involved in this process are unknown. To evaluate the influence of a number of agents on the development of the collateral circulation, we developed a rat model of severe hind limb ischaemia. The recovery of blood flow after acute arterial occlusion was increased by exogenous basic fibroblast growth factor and heparin, and decreased by protamine. Erucamide (cis-13-docosenamide), an angiogenic lipid, had no effect on collateral blood flow. These results indicate that basic fibroblast growth factor and heparin are potential therapeutic agents in the treatment of peripheral vascular disease.


Related Compounds

Related Articles:

Kinetic investigation of erucamide synthesis using fatty acid and urea.

2008-01-01

[J. Oleo Sci. 57(9) , 471-5, (2008)]

An open port sampling interface for liquid introduction atmospheric pressure ionization mass spectrometry.

2015-10-15

[Rapid Commun. Mass Spectrom. 29 , 1749-56, (2015)]

Human exposure assessment to a large set of polymer additives through the analysis of urine by solid phase extraction followed by ultra high performance liquid chromatography coupled to tandem mass spectrometry.

2015-12-04

[J. Chromatogr. A. 1423 , 111-23, (2015)]

Comparison of three gas chromatography methods for the determination of slip agents in polyethylene films.

2007-05-01

[J. Chromatogr. A. 1150(1-2) , 178-82, (2007)]

Method for determination of fatty acid amides in polyethylene packaging materials--gas chromatography/mass spectrometry.

2009-11-27

[J. Chromatogr. A. 1216(48) , 8545-8, (2009)]

More Articles...